![D. Kirkpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Kirkpatrick
Directeur Général chez
ENSYSCE BIOSCIENCES, INC.
Fortune : 31 $ au 30/06/2026
Profil
Dr. D.
L.
Kirkpatrick is a Chief Executive Officer & Director at Ensysce Biosciences, Inc. She is on the Board of Directors at Ensysce Biosciences, Inc. Dr. Kirkpatrick was previously employed as a President, Chief Executive Officer & Director by Ensysce Biosciences, Inc. /Old/, a Co-Founder by Phusis Therapeutics, Inc., a Chief Scientific Officer by CASCADIAN THERAPEUTICS INC, a President & Chief Executive Officer by ProlX Pharmaceuticals Corp., a Professor by University of Regina, and a Chief Scientific Officer by Biomira, Inc. She also served on the board at BiologicsMD, Inc. She received her undergraduate degree from the University of Saskatchewan and a doctorate degree from the University of Saskatchewan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/11/2025 | 107 ( 0 % ) | 31 $ | 30/06/2026 |
Postes actifs de D. Kirkpatrick
| Sociétés | Poste | Début |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Directeur Général | 01/01/2009 |
Anciens postes connus de D. Kirkpatrick
| Sociétés | Poste | Fin |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Directeur Technique/Scientifique/R&D | 31/12/2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Directeur Technique/Scientifique/R&D | 11/12/2007 |
ProlX Pharmaceuticals Corp.
 ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Directeur Général | 01/01/2006 |
University of Regina
 University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2001 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Fondateur | - |
Formation de D. Kirkpatrick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
University of Regina
University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
BiologicsMD, Inc.
 BiologicsMD, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical therapeutic development company which focuses on smart therapies for hair loss and bone disorders | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProlX Pharmaceuticals Corp.
ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Health Technology |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
Ensysce Biosciences, Inc.
 Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
